Relationship between serum HO-1 and other clinical parameters As shown in Fig
According to the MHRA SmPC, Ozempic is typically initiated at 0.25 mg once weekly for four weeks, then increased to 0.5 mg weekly
Por qu la semaglutida se inicia con dosis bajas
Adequate riboflavin status supports energy metabolism, muscle performance, and recovery in exercising horses
Registration Fees: 50% discount for UConn faculty/preceptors Download Event Brochure REGISTRATION LINK Patient Safety: Strength in Scoops: A Primer in Creatine, Protein Powder, and Pre-workout Supplementation Learning Objectives After completing this application-based continuing education activity, the pharmacist will be able to: Identify differences in composition and health benefits associated with creatine, protein powder, and pre-workout supplements Describe creatine dosing, common adverse effects, contraindications, and differences in available formulations Determine dietary preferences, digestion tolerance, and patient's individual health goals when selecting protein powders Provide timing and dosing for protein powder supplementation to maximize exercise recovery and muscle support After completing this application-based continuing education activity, the pharmacy technician will be able to: Identify differences in composition and health benefits associated with creatine, protein powder, and pre-workout supplements Explain common misunderstandings about the use and safety of creatine, protein powder, and pre-workout supplements Discuss nutrition labels to help patients select appropriate supplements based on patient's individual health needs Infer when to refer individuals' questions to the pharmacist Release Date: Release Date: September 20, 2025 Expiration Date: September 20, 2028 Course Fee Pharmacists: $7 Pharmacy Technicians: $4 ACPE UANs Pharmacist: 0009-0000-25-033-H05-P Pharmacy Technician: 0009-0000-25-033-H05-T Session Codes Pharmacist: 25YC33-HGJ14 Pharmacy Technician: 25YC33-JHG41 Accreditation Hours 2.0 hours of CE Accreditation Statements Disclosure of Discussions of Off-label and Investigational Drug Use The material presented here does not necessarily reflect the views of The University of Connecticut School of Pharmacy or its co-sponsor affiliates
